These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18155831)

  • 21. [Effects of hFRNK on E-cadherin/beta-catenin in colon cancer cells in vitro].
    Cao J; Yu JP; Liu CH; Chen XW; Liu S; Luo HS; Yu HG
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):346-50. PubMed ID: 17892129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of E-cadherin endocytosis by loss of protein phosphatase 2A expression in human breast cancers.
    Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2006 Oct; 349(1):255-60. PubMed ID: 16930554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells.
    Kocher HM; Sandle J; Mirza TA; Li NF; Hart IR
    Gut; 2009 Feb; 58(2):271-84. PubMed ID: 18852256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells.
    Mao Q; Li Y; Zheng X; Yang K; Shen H; Qin J; Bai Y; Kong D; Jia X; Xie L
    Biochem Biophys Res Commun; 2008 Oct; 375(4):566-70. PubMed ID: 18725195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9.
    Zhou B; Leng J; Hu M; Zhang L; Wang Z; Liu D; Tong X; Yu B; Hu Y; Deng C; Liu Y; Zhang Q
    Leuk Res; 2010 Jun; 34(6):769-76. PubMed ID: 20036004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of shRNA-CXCR4 on breast cancer cells migration and invasion].
    Li HY; Ren GS; Tan JX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):393-7. PubMed ID: 19626989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.
    Ling X; Arlinghaus RB
    Cancer Res; 2005 Apr; 65(7):2532-6. PubMed ID: 15805244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
    Ribeiro AS; Albergaria A; Sousa B; Correia AL; Bracke M; Seruca R; Schmitt FC; Paredes J
    Oncogene; 2010 Jan; 29(3):392-402. PubMed ID: 19901964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance.
    Escaffit F; Perreault N; Jean D; Francoeur C; Herring E; Rancourt C; Rivard N; Vachon PH; Paré F; Boucher MP; Auclair J; Beaulieu JF
    Exp Cell Res; 2005 Jan; 302(2):206-20. PubMed ID: 15561102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of Ezrin in gastric carcinoma and its significance].
    Shi RL; Li JF; Qu Y; Chen XH; Gu QL; Zhu ZG; Liu BY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):433-5. PubMed ID: 17043968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
    Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
    J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
    Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
    Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells.
    Stasinopoulos I; O'Brien DR; Wildes F; Glunde K; Bhujwalla ZM
    Mol Cancer Res; 2007 May; 5(5):435-42. PubMed ID: 17510310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.